NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.10
+0.85%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$3.15
From 52W high−73.83%
Volume23226.00
Market cap$89.18M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataNov 4, 2026
Open
$3.15
From 52W high
−73.83%
Volume
23226.00
Market cap
$89.18M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.0x
P/E (TTM)
—
RSI (14)
49.7
MomentumView details →
1D Return
+0.85%
YTD Return
−63.00%
SummaryUpdated Jun 1, 2026
Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) is an early-stage biotechnology company founded in 2023 and headquartered in Los Angeles, California. The company went public in March 2025 through an initial public offering. Neonc focuses on developing innovative molecular technologies designed to enhance the targeted delivery of therapeutic agents for treating central nervous system diseases, particularly brain cancers. As a clinical-stage biotech company, Neonc is currently advancing its lead drug candidates through various phases of clinical trials while burning through cash to fund research and development activities.
Similar companies
Latest newsMore news →
NEONC TECHNOLOGIES HOLDINGS, INC. outlined plans for a clinical trial targeting approximately 500 patients at 30 hospitals in three countries.9d agoNEONC TECHNOLOGIES HOLDINGS, INC. shares broke through several resistance levels on strong trading volume.12d agoNeOnc Technologies Holdings and the Department of Health – Abu Dhabi signed a memorandum of understanding to cooperate on oncology and central nervous system research and clinical capability in Abu Dhabi.14d ago